medigraphic.com
ISSN 2007-6509 (Print)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.

2014, Number 2

<< Back Next >>

Rev Mex Med Transfus 2014; 7 (2)

Apuntes sobre el Banco Central de Sangre del C.M.N. Siglo XXI en el año 2011

Ambriz FR

Language: Spanish
References: 16
Page: 8-11
PDF size: 675.25 Kb.


ABSTRACT

In the year 1998 starts the new Director Raúl Ambriz MD and his staff developed in the Central Blood Bank: The Haemophilia Centre www.wfh.org, the Committee of Blood Banks, the Committee on Stem Cell CMN Siglo XXI, Mexican Council of Hematology, Hemostasis Committee and has been the main institution for the establishment in Mexico of the Medical Association of Transfusion Medicine. The unit gives the supply of blood and its components High Specialty Hospitals, Regional and General Hospitals Area. Provides support for hemophiliacs with purified concentrates virusinactivated, specialized outpatient transfusions and makes progress in the production of components. In the year of 2011 sends every 45 days, the phenotype known panel cell to nearly 140 hospitals and thus serves as the external quality control for the country and has the backing of external quality control from of the Pan American Health Organization/World Health Organization and about the International DNA exchange with the University of California. The strategic planning was supported between the years 2007-20011.


REFERENCES

  1. Ambriz FR. Banco Central de Sangre del CMN Siglo XXI. Cua- renta y siete años de servicio en el año 2009. Rev Mex Med Tran 2011; 4: 18-30.

  2. Ambriz FR. Historia del Banco Central de Sangre del CMN Siglo XXI. Apoyo en Hemofilia. Rev Mex Med Tran 2012; 5: 29-55.

  3. Pizzuto J, Ambriz R. Therapeutic Experience on 934 Adults with Idiopathic Thrombocytopenic Purpura. Multicentrical Trial of the Cooperative Latin American Group on Hemostasis and Thrombosis. Blood 1984; 64: 1179-1183.

  4. Ambriz R, Muñoz R, Pizzuto J, Quintanar E, Morales M, Avilés A. Low –Dose Autologous In Vitro Opsonized Erythocytes. Ra- dioimmune Method and Autologous Opsonized Erythrocytes for Refractory Autoimmune Thrombocytopenic Purpura. Arch Intern Med 1987; 147: 105-108.

  5. Ambriz FR, C. Martínez MC, Quintana GS, Collazo JJ, J. Bau- tista JJ. Fc receptor blockade in patients with refractory chro- nic immune thromcytopenic purpura with anti-D IgG. Arch Med Res, 2002; 33: 536-540.

  6. George JN, Wolf H, Raskob GE, Wasser JS, Aledort LM, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloo JA, Reagan DH, Warrier I. Idiopathic Thrombocytopenic Purpura: a practice guideline developed by explicit methods for the American Society of Hematology Blood 1996; 88: 3-40

  7. British Comittee of Standards in Haematology General Hae- matology Task Force. Guidelines for the investigation and ma- nagement of idiopathic thrombocytopenic purpura in adults, children and pregnancy. Br J Haematol 2003; 120: 574-596

  8. Godeau B, Provan B, Bussel J. Immune thrombocytopenic purpura in adults. Current Opinion in Hematology 2007; 14: 535-556.

  9. Rivera LMRF, Ambriz FR, Zavala MC, Portillo LL, Collazo JJ, Sánchez CA. Fraccionamiento por el sistema Atreus, nuevo procedimiento. Gac Méd Mex 2007; 143 supl 2: 13-17.

  10. Ambriz FR, Mejía AM. Eds. XLV Aniversario, Banco Central de Sangre CMN Siglo XXI. Gac Méd Méx 2007; 143 supl 2: 1-90.

  11. Martínez AJC, Arrazola A, Suarez A, Alcaraz JL. Use of polymerase Chaín reaction to determine Diego-b antigen using specific sequence primers (SSP ). Vox Sang 2010; 99 suppl 1: 335.

  12. Martínez AJC, Navarrete RAP, Arrazola GA, Suárez CA, Zana- na NA, Camargo CA, García RB, Rivera LRR, Ambriz FR, Jimé- nez BFJ. Subtipos HLA-B27 en familias de pacientes mestizos mexicanos con espondilitis anquilosante. Rev Mex Med Tran 2008; 1: 18-22.

  13. Cruz M, Valladares SA, García MJ, Ángeles MJ, Ortega CC, Escobedo de la PJ, Burguete GAI, Wacher RN, Ambriz R, Ri- vera R, D´artote AL, Peralta J, Parra EJ, Kumate J. Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from México City. Diabetes Metab Res Rev 2010; 26: 261-270.

  14. Ambriz FR, Rivera LR, Portillo ML, Bonilla ZR. Blood donation waiting time obtained by automated standards in México. Vox Sang 2010; 99 suppl 1: 135.

  15. Ambriz FR, Portillo LML, Rivera LR, D´Artote GAL. Implemen- tación de estándares en el tiempo de espera en el proceso de donación de sangre. Rev Mex Med Tran 2010; 3: 7-13.

  16. Ambriz FR, Rivera LR, García, Bonilla ZR, Betacourt L. Justo a Tiempo. Programa para disminuir el tiempo de espera del donador en el año 2011. Una contribución original con mé- todos automatizados y aumento de la competitividad en una institución pública. Rev Mex Med Tran 2012; 5: 6-18.




2020     |     www.medigraphic.com